Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F3TRW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,419
Award facts
- Contract value 100% obligated
- $17,418.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,418.96 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder in 60-dose units. This firm fixed-price delivery order, which was not set aside for any specific business category, is scheduled for completion by January 16, 2026, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. The award falls under the company's broader relationship with DLA as a critical pharmaceutical distributor serving military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which maintains a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a vast range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. Trelegy Ellipta is a combination respiratory therapy medication used in the treatment of chronic obstructive pulmonary disease, reflecting the breadth of pharmaceutical products that AmerisourceBergen supplies through its federal contracting relationships to support military treatment facilities and other government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F3TRW?
SPE2DR26F3TRW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F3TRW worth?
The government has obligated $17,419 on SPE2DR26F3TRW.
Is contract SPE2DR26F3TRW an order under another contract?
Yes. SPE2DR26F3TRW is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TRW competed?
The extent of competition for SPE2DR26F3TRW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award